Form 4: RxSight CFO Shelley Thunen Executes Stock Option and Sells Shares
SEC Form 4
Shelley Thunen, CFO of RxSight, Inc., exercised stock options and sold shares on July 1, 2024, according to a Form 4 filing with the SEC.
Summary
- On July 1, 2024, Shelley Thunen, the Chief Financial Officer of RxSight, Inc., exercised a stock option to acquire 10,000 shares of common stock at a price of $15.5983 per share.
- Concurrently, Thunen sold a total of 18,402 shares of common stock in multiple transactions at prices ranging from $58.205 to $59.725 per share.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 14, 2023.
- Following these transactions, Thunen directly owns 13,938 shares and indirectly owns 0 shares through a family trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Future Outlook
The document does not contain specific forward-looking statements, but the Rule 10b5-1 trading plan suggests a pre-determined strategy for future transactions.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Stakeholder Impact
- The stock sales could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2021-03-22 | Vesting Commencement Date for the stock options. |
| 2023-09-14 | Date of adoption of the Rule 10b5-1 trading plan. |
| 2024-07-01 | Date of the stock option exercise and stock sales. |
| 2024-07-02 | Date of signature on the Form 4 filing. |
| 2031-03-22 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.